PTJ
EBS icon

Paul Tudor Jones’s Emergent Biosolutions EBS Stock Holding History

Paul Tudor Jones’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,464
Closed -$58.7K – 2352
2023
Q4 		$58.7K Buy
24,464
+2,081
+9% +$4.89K ﹤0.01% 2264
2023
Q3 		$76.1K Buy
+22,383
New +$124K ﹤0.01% 2166
2022
Q2 		– Sell
-32,557
Closed -$1.34M – 2206
2022
Q1 		$1.34M Buy
+32,557
New +$1.44M 0.03% 747
2021
Q4 		– Sell
-35,580
Closed -$1.78M – 2561
2021
Q3 		$1.78M Buy
35,580
+30,787
+642% +$1.86M 0.03% 793
2021
Q2 		$302K Sell
4,793
-4,100
-46% -$263K 0.01% 1340
2021
Q1 		$826K Sell
8,893
-7,756
-47% -$794K 0.02% 927
2020
Q4 		$1.49M Buy
+16,649
New +$1.53M 0.04% 541
2017
Q2 		– Sell
-7,000
Closed -$203K – 1103
2017
Q1 		$203K Sell
7,000
-2,700
-28% -$82.2K 0.01% 1217
2016
Q4 		$319K Buy
+9,700
New +$291K 0.01% 986
2016
Q3 		– Sell
-16,200
Closed -$456K – 1495
2016
Q2 		$456K Sell
16,200
-8,432
-34% -$331K 0.01% 902
2016
Q1 		$895K Sell
24,632
-2,164
-8% -$76.4K 0.02% 577
2015
Q4 		$1.07M Sell
26,796
-5,570
-17% -$194K 0.03% 415
2015
Q3 		$922K Buy
32,366
+17,066
+112% +$562K 0.03% 419
2015
Q2 		$504K Buy
15,300
+2,608
+21% +$80.9K 0.01% 774
2015
Q1 		$365K Buy
12,692
+5,192
+69% +$149K 0.01% 927
2014
Q4 		$204K Sell
7,500
-16,500
-69% -$393K 0.01% 1267
2014
Q3 		$511K Sell
24,000
-5,400
-18% -$124K 0.02% 658
2014
Q2 		$660K Buy
29,400
+8,657
+42% +$202K 0.03% 387
2014
Q1 		$524K Buy
+20,743
New +$524K 0.02% 496
2013
Q3 		– Sell
-21,900
Closed -$316K – 841
2013
Q2 		$316K Buy
+21,900
New +$317K 0.02% 528

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Paul Tudor Jones's EBS Position: Q1 2024 in Review

Paul Tudor Jones sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 24,464 shares — an estimated $58.7K sold.

Paul Tudor Jones first reported a position in EBS in Q2 2013 and held it in 20 quarters. The position peaked at $1.78M in Q3 2021. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • Paul Tudor Jones reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 24,464 Emergent Biosolutions shares in Q1 2024, an estimated $58.7K.
  • Paul Tudor Jones first reported a position in Emergent Biosolutions in Q2 2013 and held it in 20 quarters.
  • Paul Tudor Jones's Emergent Biosolutions position peaked at $1.78M in Q3 2021.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.